Aurobindo to Start US Units This Year; China Plant Nears Q3 FY26 Break-Even
New Delhi, August 18, 2025 — Aurobindo Pharma said two manufacturing units in the United States are slated to start production within the current fiscal, tightening the company’s supply chain…
Senores Pharma to Buy Two Teva ANDAs
Mumbai, August 14, 2025 — Senores Pharmaceuticals will acquire two abbreviated new drug applications (ANDAs) from Teva Pharmaceuticals USA. The deal is Senores’ third US move in six months, underscoring…
Imports of Essential Bulk Drugs Drop 12% in June on Rising Domestic API Output
New Delhi, August 5, 2025 — India’s pharmaceutical sector is showing strong signs of self-reliance, as imports of bulk drugs and drug intermediates declined for the third consecutive month in…
Mankind Pharma Q1 FY26 Net Profit Falls 17% to ₹378 Cr; Declares ₹5 Dividend
Mankind Pharma reported a 17% year-on-year drop in consolidated net profit to ₹378 crore in Q1 FY26, despite an 11% rise in revenue. The company also declared a ₹5 per…
